Friday, May 20, 2022
No Result
View All Result
Medical Finance
  • Home
  • News
  • Interviews
  • Mediknowledge
  • Insights From Industry
  • Thought Leaders
  • Coronavirus
  • Whitepapers
  • Home
  • News
  • Interviews
  • Mediknowledge
  • Insights From Industry
  • Thought Leaders
  • Coronavirus
  • Whitepapers
No Result
View All Result
Medical Finance
No Result
View All Result
Home Coronavirus

Fear of getting sick with COVID-19 linked to increase in disgust sensitivity

by Medical Finance
in Coronavirus
Surveying communities may be a useful tool for predicting COVID-19 case trajectories
10
SHARES
108
VIEWS
Share on FacebookShare on Twitter

Theory has it that disgust sensitivity – how intensely a person is repulsed by images, ideas or situations that could be considered terribly gross or merely unpleasant – is an evolutionary trait that initially helped humans avoid eating rotten food that would have made them sick.

Research has since shown that disgust sensitivity, as measured on a specific scale, can differ widely, with some individuals experiencing disgust very strongly and others less so. But the explanation for those differences is subject to debate. Is high disgust sensitivity the result of growing up with germophobes, related to neuroticism, or a way to detect an unfit sexual partner? And is disgust stable across the lifespan, or can it change?

A new study suggests disgust sensitivity can and does change – and, during the COVID-19 pandemic, concern about getting sick with a coronavirus infection was associated with an increase in disgust sensitivity.

Ohio State University researchers who had collected disgust sensitivity data for a larger project before the coronavirus outbreak compared those measures to similar data collected during and after pandemic lockdowns.

“What hasn’t been tested thoroughly is the extent to which your environment actually shapes your disgust sensitivity. What happens when you’re in an environment that has a lot of pathogens?” said Shelby Boggs, a doctoral student in psychology at The Ohio State University and first author of the study. “Disgust sensitivity was higher in studies we ran during the pandemic, but particularly higher for people who felt concerned they would actually contract COVID-19.”

Boggs conducted the study with senior author Russell Fazio, professor of psychology at Ohio State, and former postdoctoral researcher Benjamin Ruisch, who is now at Leiden University.

The research is published in the February 2022 issue of the journal Personality and Individual Differences.

Despite disgust sensitivity’s origins in dodging disease, research over the years has linked high disgust sensitivity to avoidance of “others” – people of different races, political ideologies or genders, for example. That school of thought leans toward considering disgust sensitivity an unchanging individual difference.

The Ohio State researchers focused on – and found evidence to support – what is known as the “calibration hypothesis,” which suggests that disgust sensitivity is a more fluid measure that changes with time and circumstance.

This study involved nine surveys conducted between late 2018 and June 2020. Before the pandemic, the team collected data from about 2,300 participants in seven waves that included assessment of their disgust sensitivity. The pandemic’s arrival in spring 2020 opened up an opportunity for a natural experiment to test the question of environmental effects on disgust sensitivity.

The researchers conducted two more surveys in late spring 2020, of 500 people each, questioning participants about a variety of their pandemic-related opinions and behaviors – including how concerned they were that they might contract COVID-19 – and assessing their disgust sensitivity. The first was an entirely new group of participants, but the second was a subset of people who had participated in the pre-pandemic surveys – providing a rare longitudinal look at disgust sensitivity.

“Instead of comparing two groups of people pre- and post-pandemic, you’re comparing the same people and finding that to the extent that you perceive yourself at risk of contracting COVID, we get this heightened disgust sensitivity,” Fazio said. “That’s powerful.

“The increase in disgust sensitivity really being limited to those people who were concerned about contracting COVID-19 also eliminated a number of alternative explanations for the data.”

Part of the disgust sensitivity scale asks participants to rate various experiences – such as smelling urine while walking in a tunnel under a railroad track or seeing someone put ketchup on vanilla ice cream and eat it – on a scale of 0 to 4, where 4 is extremely disgusting.

The pre-pandemic average disgust sensitivity was 2.82, a figure that increased to 3.26 during the pandemic. These results, based on the way disgust sensitivity is measured, showed that people were not repelled only by disease-related scenarios but also scenarios that had nothing to do with disease transmission – a sign that their entire disgust sensitivity profile was heightened.

“One item on the rating asks how disgusted you would be if you were on an elevator and someone next to you sneezed. Another asks whether you’d be disgusted by eating chocolate shaped like dog doo – which has nothing to do with interacting and contracting a disease,” Boggs said.

Fazio noted that the enhanced sensitivity was also evident when participants were asked to rate various visual images related to disgust, such as rotten meat with maggots in it. Those who were concerned about contracting the virus found the images more unappealing – meaning the effect extended beyond the items measured by the assessment scale.

Boggs predicted that once the most serious threats of the pandemic ease, disgust sensitivity in people concerned about getting sick would habituate to pre-pandemic levels.

“Experiencing disgust all the time is not a fun state to be in. It’s a very vigilant emotion,” she said. “My suspicion is if we recontacted people a year or two out of pandemic mode, they probably would have gone back down in disgust sensitivity levels. If the threat subsides, then presumably your disgust sensitivity should subside as well.”

This work was supported by the National Science Foundation.

Source:

Journal reference:

Boggs, S.T., et al. (2021) Concern about salient pathogen threats increases sensitivity to disgust. Personality and Individual Differences. doi.org/10.1016/j.paid.2021.111348.

Total
0
Shares
Share 0
Tweet 0
Pin it 0
Share 0
Medical Finance

Medical Finance

Related Posts

Study: Risk of infection, hospitalisation, and death up to 9 months after a second dose of COVID-19 vaccine: a retrospective, total population cohort study in Sweden. Image Credit: Novikov Aleksey/Shutterstock

Effectiveness of COVID-19 vaccination 9 months post-vaccination for the population of Sweden

by Medical Finance
May 20, 2022
0

The coronavirus disease 2019 (COVID-19) vaccines BNT162b2 (Pfizer-BioNTech), mRNA-1273 (Moderna), and ChAdOx1 nCoV-19 (Oxford-AstraZeneca) have all shown excellent efficacy...

Nutritional components hold promise for improving the health and well-being of adults

New study helps explain the immune system’s response to skin infections and skin cancers

by Medical Finance
May 20, 2022
0

It is well established that older adults are more susceptible to infection and their immune systems less capable of generating...

Study: Duration of protection of BNT162b2 and mRNA-1273 COVID-19 vaccines against symptomatic SARS-CoV-2 Omicron infection in Qatar. Image Credit: Syda Productions/Shutterstock

mRNA COVID-19 vaccines shown to provide high level of protection against severe SARS-CoV-2 omicron infection

by Medical Finance
May 20, 2022
0

Scientists from Qatar have recently studied the duration of protection provided by mRNA-based coronavirus disease 2019 (COVID-19) vaccines against symptomatic...

Nearly 13% of the patients hospitalized for COVID-19 had serious neurologic symptoms

Nearly 13% of the patients hospitalized for COVID-19 had serious neurologic symptoms

by Medical Finance
May 20, 2022
0

Overwhelming evidence shows that infection with severe acute respiratory syndrome (SARS-CoV-2) causes dysfunction of multiple organ systems, including the nervous...

Study: ARTIFICIAL INTELLIGENCE TOOLS FOR EFFECTIVE MONITORING OF POPULATION AT DISTANCE DURING COVID-19 PANDEMIC. RESULTS FROM AN ITALIAN PILOT FEASIBILITY STUDY (RICOVAI-19 STUDY). Image Credit: elenabsl/Shutterstock

AI based home monitoring during COVID-19 pandemic

by Medical Finance
May 20, 2022
0

In a recent study posted to the medRxiv* preprint server, an interdisciplinary team of researchers conducted an open, prospective...

Study: Effect of oral nirmatrelvir on Long COVID symptoms: a case series. Image Credit: Donkeyworx / Shutterstock

Oral Nirmatrelvir’s effects on long COVID symptoms

by Medical Finance
May 20, 2022
0

In a recent study posted to the Research Square* preprint server, researchers at the University of California, San Francisco, examined...

Next Post
​​​​​​​Study: Biochemical Characterization of Emerging SARS-CoV-2 Nsp15 Endoribonuclease Variants. ​​​​​​​Image Credit: NIAID

Characterizing SARS-CoV-2 non-structural protein 15 endoribonuclease variants

Study: The Tabula Sapiens: A multiple-organ, single-cell transcriptomic atlas of humans. Image Credit: ktsdesign / Shutterstock

Tabula sapiens, most comprehensive human cell atlas

0 0 votes
Article Rating
Subscribe
Login
Notify of
guest
guest
0 Comments
Inline Feedbacks
View all comments

Support

  • Contact
  • Disclaimer
  • Home
  • Privacy Policy
  • Terms And Conditions

Categories

  • Coronavirus
  • Insights From Industry
  • Interviews
  • Mediknowledge
  • News
  • Thought Leaders
  • Whitepapers

More News

  • Study: Clinical severity of Omicron sub-lineage BA.2 compared to BA.1 in South Africa. Image Credit: peterschreiber.media/Shutterstock
    Severity of SARS-CoV-2 infections with Omicron BA.2 variant relative to the BA.1 variant in South Africa
  • Study: Safety and immunogenicity of SARS-CoV-2 vaccine MVC-COV1901 in adolescents in Taiwan: A double-blind, randomized, placebo-controlled phase 2 trial. Image Credit: Ken stocker/Shutterstock
    Phase 2 trial evaluates the safety and immunogenicity of two doses of the SARS-CoV-2 vaccine MVC-COV1901 in adolescents
  • Home
  • Privacy Policy
  • Contact
  • Disclaimer
  • Terms And Conditions

© 2022 Medical Finance - Latest Financial and Business News

No Result
View All Result
  • Interviews
  • Mediknowledge
  • News
  • Insights From Industry
  • Coronavirus
  • Thought Leaders
  • Whitepapers
wpDiscuz
0
0
Would love your thoughts, please comment.x
()
x
| Reply